Welcome to our dedicated page for Wolters Kluwer N V news (Ticker: WTKWY), a resource for investors and traders seeking the latest updates and insights on Wolters Kluwer N V stock.
Wolters Kluwer N.V. (WTKWY) delivers professional information and software solutions across healthcare, legal, finance, and compliance sectors through integrated digital platforms and AI-driven tools. This page aggregates official announcements and verified news developments critical for understanding the company’s market position.
Access real-time updates on earnings reports, regulatory compliance innovations, strategic partnerships, and technology advancements. Investors and professionals benefit from organized access to press releases detailing product launches, governance updates, and operational milestones that shape industry leadership.
Key content categories include regulatory guidance updates, AI-powered solution developments, financial performance disclosures, and strategic market expansions. Each update is curated to support informed analysis of the company’s role in professional services digitalization.
Bookmark this page for streamlined tracking of Wolters Kluwer’s initiatives in legal compliance systems, healthcare information tools, and ethical AI applications. Combine regular monitoring with sector-specific analysis tools for comprehensive investment research.
Wolters Kluwer Health responds to the World Health Organization's declaration of monkeypox as a global health emergency by providing free access to UpToDate resources and a dedicated monkeypox resource page. This initiative aims to equip clinicians worldwide with the latest evidence-based information to treat patients effectively. The company emphasizes its commitment to supporting healthcare professionals during this outbreak.
Wolters Kluwer Tax & Accounting highlights critical tax proposals under consideration by Congress that could influence tax planning for 2022 and beyond. The proposals include a scaled-down version of the Build Back Better Act, which focuses on drug pricing and climate change provisions, alongside extending certain elements of the Tax Cuts and Jobs Act. Other notable discussions involve denying tax benefits to companies operating in Russia and reforming tax-favored savings requirements. With Congress nearing a recess for elections, timely action on these measures is essential.
Wolters Kluwer Compliance Solutions announces the expansion of Ginnie Mae’s Digital Collateral Program, effective
Wolters Kluwer Finance, Risk & Regulatory Reporting (FRR) has achieved significant recognition, winning three awards at the 2022 South East Asia Business Awards. The company was awarded Best Risk Firm and Best Regulatory Reporting Firm, showcasing its excellence in risk and regulatory reporting. Additionally, Rainer Fuchsluger, Managing Director of Wolters Kluwer FRR APAC, earned the title RegTech Executive Leader of the Year, APAC. This recognition affirms Wolters Kluwer's position as a leader in providing integrated compliance and reporting solutions for financial institutions.
Wolters Kluwer Legal & Regulatory U.S. announced a partnership with Lawgood to integrate the VitalLaw Agreement & Clause Builder tool. This feature allows legal professionals to draft contracts more efficiently by utilizing crowdsourced market intelligence. Users can customize agreements based on jurisdiction and industry while accessing insights from similar attorneys. The new tool is expected to enhance productivity for attorneys facing cost pressures. Wolters Kluwer reported annual revenues of €4.8 billion and operates globally across various sectors.
Wolters Kluwer, Health announced enhancements to its Lippincott® portfolio, introducing Lippincott Preprints and the Lippincott Data Repository. These platforms facilitate the rapid sharing of medical research and clinical data, responding to the increased demand for transparency and accessibility within the medical community. Lippincott Preprints allows researchers to share findings before peer review, while the Data Repository supports the sharing of research data, improving the validation process. This move aligns with the growing need for open access medicine and aims to enhance the quality and pace of scientific communication.